Feed NRXBF
NR

NurExone Biologic Inc.

NRXBF · OTC

$0.45 +6.84% (+$0.03)
1M +38.37%
Valuation
-
N/A
P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A
Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A
FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A
Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A
Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
47 /100
Moderate
Beta 0.39x
EPS volatility N/A
Profitable years N/A

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o NRXBF
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Lior Shaltiel

Employees

16

Headquarters

Toronto

Prihajajoči dogodki

25 NOV.

Earnings

Upcoming earnings report

81d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.